Decanoyl-RVKR-CMK (DecRVKRcmk) TFA inhibits over-expressed gp160 processing and HIV-1 replicationIn VitroDecanoyl-RVKR-CMK (DecRVKRcmk) TFA inhibits HIV-2 ROD replication by blocking envelope glycoprotein precursor processing in the Jurkat lymphocyte cell. ?/nDecanoyl-RVKR-CMK (DecRVKRcmk) TFA blocks regulated secretion of VGF. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Viability AssayCell Line: HeLaCD4 cells infected with recombinant vaccinia viruses at a multiplicity of infection (MOI) of 5 PFU/mL Concentration: 35 and 70 µΜ Incubation Time: 7 days Result: Peptide at 35 µM significantly inhibited ex vivo HIV-1 and HIV-2 replications (70-80% inhibition).Form:SolidIC50& Target:HIV-1 HIV-2.
Specifications and Purity: ≥96%
Molecular Formula: C36H67ClF3N11O7
Molecular Weight: 858.43
- UPC:
- 12141756
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- D651858-10mg
- CAS:
- 2098497-25-5
- Product Size:
- 10mg
akash.verma@cenmed.com
(732) 447-1115





